# MiNK Therapeutics, Inc.: Form 8-K, filed Mar 18, 2025

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: 8-K
- Filed: 2025-03-18
- Accepted by EDGAR: Mar 18, 2025, 07:30 ET
- Period: 2025-03-18
- Accession: 0001171843-25-001513
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000117184325001513/f8k_031825.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000117184325001513/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000117184325001513/f8k_031825.htm

Filed Mar 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-001513. Last ingested by Listed: Nov 12, 2026, 21:09 ET. No prices; not investment advice.
